Joanne Wuensch
Stock Analyst at Citigroup
(4.30)
# 425
Out of 5,002 analysts
407
Total ratings
63.24%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Downgrades: Neutral | $97 → $72 | $69.12 | +4.17% | 21 | Aug 28, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $10 → $11 | $13.11 | -16.09% | 19 | Aug 21, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.6 → $4.5 | $3.30 | +36.57% | 12 | Aug 21, 2025 | |
| MDT Medtronic | Maintains: Buy | $99 → $101 | $95.48 | +5.78% | 21 | Aug 21, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $185 → $200 | $185.98 | +7.54% | 13 | Aug 21, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $167 → $183 | $173.81 | +5.29% | 20 | Aug 21, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $89 → $93 | $76.82 | +21.06% | 6 | Jul 31, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $157 → $155 | $132.99 | +16.55% | 22 | Jul 18, 2025 | |
| PEN Penumbra | Maintains: Neutral | $320 → $285 | $253.49 | +12.43% | 25 | Jul 9, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $38 → $47 | $42.23 | +11.30% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $34 → $32 | $23.23 | +37.75% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $14.76 | +1.63% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $71 → $90 | $48.90 | +84.05% | 8 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $366.40 | +24.18% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.69 | +145.56% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $443.01 | +46.72% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $312.21 | +21.71% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $76.65 | +23.94% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $102 | $66.44 | +53.52% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $96.22 | +29.91% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $103.09 | +35.80% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $84.49 | +91.74% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $13.97 | +57.48% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $99.17 | +21.00% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $191.60 | +30.48% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $75.11 | -8.13% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $276.64 | -54.09% | 6 | Dec 10, 2018 |
The Cooper Companies
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $69.12
Upside: +4.17%
Tandem Diabetes Care
Aug 21, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $13.11
Upside: -16.09%
Sight Sciences
Aug 21, 2025
Maintains: Neutral
Price Target: $3.6 → $4.5
Current: $3.30
Upside: +36.57%
Medtronic
Aug 21, 2025
Maintains: Buy
Price Target: $99 → $101
Current: $95.48
Upside: +5.78%
Johnson & Johnson
Aug 21, 2025
Maintains: Buy
Price Target: $185 → $200
Current: $185.98
Upside: +7.54%
iRhythm Technologies
Aug 21, 2025
Maintains: Buy
Price Target: $167 → $183
Current: $173.81
Upside: +5.29%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Buy
Price Target: $89 → $93
Current: $76.82
Upside: +21.06%
Abbott Laboratories
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $132.99
Upside: +16.55%
Penumbra
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $253.49
Upside: +12.43%
Establishment Labs Holdings
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $42.23
Upside: +11.30%
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $23.23
Upside: +37.75%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $14.76
Upside: +1.63%
Jul 9, 2025
Upgrades: Buy
Price Target: $71 → $90
Current: $48.90
Upside: +84.05%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $366.40
Upside: +24.18%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.69
Upside: +145.56%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $443.01
Upside: +46.72%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $312.21
Upside: +21.71%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $76.65
Upside: +23.94%
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $66.44
Upside: +53.52%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $96.22
Upside: +29.91%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $103.09
Upside: +35.80%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $84.49
Upside: +91.74%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $13.97
Upside: +57.48%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $99.17
Upside: +21.00%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $191.60
Upside: +30.48%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $75.11
Upside: -8.13%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $276.64
Upside: -54.09%